Viridian Therapeutics, Inc. Common Stock
VRDN •
Sell Open
Signal type
Sell
Status
Open
Open Price
$13.62
Stop Loss
$15.80
Performance
-11.53%
Days Open
9
Signal Setup
Signal Type Sell
Status Open
Open Date Apr 6, 2026
Open Price $13.62
Stop Loss $15.80
Timespan Day
Company Profile
Name Viridian Therapeutics, Inc. Common Stock
Ticker VRDN
Market Cap $1.14B
Sector SERVICES-MEDICAL LABORATORIES
Latest Close $15.19
List Date Jun 18, 2014
Description
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
Website Open Company Website